[go: up one dir, main page]

IL61114A0 - New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL61114A0
IL61114A0 IL61114A IL6111480A IL61114A0 IL 61114 A0 IL61114 A0 IL 61114A0 IL 61114 A IL61114 A IL 61114A IL 6111480 A IL6111480 A IL 6111480A IL 61114 A0 IL61114 A0 IL 61114A0
Authority
IL
Israel
Prior art keywords
radical
group
phenoxyalkylpiperidine
derivatives
processes
Prior art date
Application number
IL61114A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL61114A0 publication Critical patent/IL61114A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL61114A 1979-09-28 1980-09-23 New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them IL61114A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792939292 DE2939292A1 (de) 1979-09-28 1979-09-28 N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
IL61114A0 true IL61114A0 (en) 1980-11-30

Family

ID=6082088

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61114A IL61114A0 (en) 1979-09-28 1980-09-23 New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US4348401A (xx)
EP (1) EP0026876B1 (xx)
JP (1) JPS5668669A (xx)
AT (1) ATE2519T1 (xx)
CA (1) CA1139759A (xx)
CS (1) CS219950B2 (xx)
DD (1) DD153117A5 (xx)
DE (2) DE2939292A1 (xx)
ES (1) ES495412A0 (xx)
IL (1) IL61114A0 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
HU215397B (hu) * 1994-08-29 1998-12-28 Richter Gedeon Vegyészeti Gyár Rt. (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
WO2003076395A1 (en) * 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
JP4725945B2 (ja) 2002-03-13 2011-07-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの新規な阻害剤としてのスルホニルアミノ誘導体
WO2003076400A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. New inhibitors of histone deacetylase
ES2307909T3 (es) * 2002-03-13 2008-12-01 Janssen Pharmaceutica Nv Derivados de piperazinil, piperidinil y morfolinil como nuevos inhidbidores de la histona deacetilasa.
NZ552865A (en) 2004-07-28 2009-09-25 Janssen Pharmaceutica Nv Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
EP1867332B1 (en) * 2005-04-07 2011-08-24 Toyama Chemical Co., Ltd. Pharmaceutical composition and method using antifungal agent in combination
US8138198B2 (en) 2005-05-18 2012-03-20 Angibaud Patrick Rene Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
CA2631874C (en) * 2006-01-19 2014-11-18 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
ES2327972T3 (es) * 2006-01-19 2009-11-05 Janssen Pharmaceutica, N.V. Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
EP1979326B1 (en) 2006-01-19 2012-10-03 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JP5137849B2 (ja) * 2006-01-19 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしての置換インドリル−アルキル−アミノ−誘導体
EP2865381A1 (en) 2006-05-18 2015-04-29 Pharmacyclics, Inc. ITK inhibitors for treating blood cell malignancies
KR102077864B1 (ko) 2012-08-01 2020-02-14 쇼와 덴코 패키징 가부시키가이샤 내용물 부착 방지 덮개재

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255196A (en) * 1966-06-07 Phenoxyalkyl piperidine derivatives
CH426811A (fr) * 1962-02-28 1966-12-31 Rhone Poulenc Sa Procédé de préparation de nouveaux dérivés de la pipéridine
US3691176A (en) * 1970-05-25 1972-09-12 Abbott Lab 1-(4-fluorophenoxypropyl)-4-anilino-piperidines
DE2341376A1 (de) * 1972-08-24 1974-03-07 Ciba Geigy Ag Piperidin-derivate und verfahren zu ihrer herstellung
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE2939292A1 (de) 1981-04-09
DE3062052D1 (en) 1983-03-24
EP0026876B1 (de) 1983-02-16
ES8105729A1 (es) 1981-06-16
US4348401A (en) 1982-09-07
ATE2519T1 (de) 1983-03-15
EP0026876A1 (de) 1981-04-15
CA1139759A (en) 1983-01-18
JPS5668669A (en) 1981-06-09
CS219950B2 (en) 1983-03-25
ES495412A0 (es) 1981-06-16
DD153117A5 (de) 1981-12-23

Similar Documents

Publication Publication Date Title
IL61114A0 (en) New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
ES2032750T3 (es) Profarmacos de rapamicina.
MX9800577A (es) Derivados de 4,5-diaril oxazol.
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
SE8000205L (sv) Nya heterotricykliska derivat, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa derivat
CA2093403A1 (en) Therapeutic agent for parkinson's disease
EA200501104A1 (ru) Производные пиридина, пригодные для ингибирования системы обмена натрия/кальция
EP0096517A3 (en) Aryl pyrazinones
NZ331801A (en) Therapeutic agent for diabetes
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
AU572690B2 (en) Tricyclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
EP0254495A3 (en) Beta-lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
DE3162053D1 (en) N-acyl peptide compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
IE800834L (en) 7-n-heterocyclyl cephalosporins
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
ES8100275A1 (es) Un procedimiento para la preparacion de derivados de 5-fluoruracilo
IL59507A (en) 5-(10-9)abeo-6-methylergoline derivatives,their preparation and pharmaceutical compositions containing them
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
ATE170860T1 (de) Antibiotische carbapenemverbindungen